Document is current
Any future updates will be listed below
-
Authors
Spalluto, Lucy B. https://orcid.org/0000-0002-9821-3498
Bonnet, Kemberlee
Schlundt, David
Audet, Carolyn M.
Henschke, Claudia I.
Yankelevitz, David F.
York, Sally J.
Hendler, Fred
Dittus, Robert S.
Moghanaki, Drew
Roumie, Christianne L.
Lewis, Jennifer A.
-
Funding
Funding for this research was provided by:
Office of Rural Health
VA Lung Precision Oncology Program
Clinical Science Research and Development (CIN 24-128)
Conquer Cancer Foundation (2021YIA-9865677411)
LUNGevity Foundation (2021-08)
National Cancer Institute (CA68485)
National Heart, Lung, and Blood Institute (K12HL137943)
Bristol Myers Squibb Foundation
- License Information
-
More Information
Article History
Received: 3 February 2025
Accepted: 30 June 2025
First Online: 25 July 2025
Declarations
:
: Study team personnel obtained informed consent via telephone from all study participants. Participation incentives were not offered.
: Drs. Lewis is a medical co-director and Dr. Spalluto is a Steering Committee Member of their VA’s lung cancer screening program. Dr. Lewis is the Treasurer of the Rescue Lung Rescue Life Society but does not receive financial compensation for this role. Dr. Yankelevitz is a named inventor on a number of patents and patent applications relating to the evaluation of diseases of the chest including measurement of nodules. Some of these, which are owned by Cornell Research Foundation (CRF), are non-exclusively licensed to General Electric. As an inventor of these patents, Dr. Yankelevitz is entitled to a share of any compensation which CRF may receive from its commercialization of these patents. He is also an equity owner in Accumetra, a privately held technology company committed to improving the science and practice of image-based decision making. Dr. Yankelevitz also serves on the advisory board of GRAIL. Dr. Henschke is the President and serves on the board of the Early Diagnosis and Treatment Research Foundation. She receives no compensation from the Foundation. The Foundation is established to provide grants for projects, conferences, and public databases for research on early diagnosis and treatment of diseases. Dr. Henschke is also a named inventor on a number of patents and patent applications relating to the evaluation of pulmonary nodules on CT scans of the chest, which are owned by Cornell Research Foundation (CRF). Since 2009, Dr. Henschke does not accept any financial benefit from these patents including royalties and any other proceeds related to the patents or patent applications owned by CRF.
